Company CTCBIO Inc.

Company CTCBIO Inc.

A060590

KR7060590007

Pharmaceuticals

Equities

A060590

KR7060590007

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Veterinary Drugs

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Veterinary Drugs

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
8,010 ^KRW	-0.87%		+2.96%	-25.14%

Apr. 24	Korean Sugar Imports Plunge 14% as Diabetes Cases Surge	MT
Mar. 21	CTCBIO Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

CTCBIO Inc. is a Korea-based company engaged in the manufacture and marketing of pharmaceuticals, veterinary drugs, animal feed supplements and functional foods. It pharmaceuticals include anticancer agents, antibiotics, bone injury treatments, antiulcer agents, blood flow stimulants and others. Its veterinary drugs include vaccines, antibiotics, immune enhancers, enzymes, organic acid, avian influenza-related agents and others. Its animal feed supplements include pigments, kapok seed meal, sesame meal and others. Its functional food business includes the development and manufacture of enzymes, lactobacillus and related products mainly used in dairy products. It also involves in the development of pharmaceutical manufacturing technology and know-how. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 233

KRW in Million	2022	Weight	2023	Weight	Delta
Animal and Human Medicine 84.4 %	139,445	84.4 %	116,350	84.4 %	-16.56%
Hay 18.1 %	32,905	19.9 %	24,934	18.1 %	-24.22%
Consolidated Adjustment -3.8 %	-8,596	-5.2 %	-5,254	-3.8 %	-38.88%
Health Functional Food 1.3 %	1,453	0.9 %	1,848	1.3 %	+27.20%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 102.5 %	172,349	104.3 %	141,285	102.5 %	-18.02%
Consolidated Adjustment -3.8 %	-8,596	-5.2 %	-5,254	-3.8 %	-38.88%
Overseas 1.3 %	1,453	0.9 %	1,848	1.3 %	+27.20%

Managers	Title	Age	Since
Min-Ku Lee CEO	Chief Executive Officer	-	-
Hyun-Mok Park PSD	President	57	-
Sang-Ho Bae AUD	Comptroller/Controller/Auditor	78	-

Members of the board	Title	Age	Since
Jun-Seok Byun BRD	Director/Board Member	52	-
Min-Ku Lee CEO	Chief Executive Officer	-	-
Geum-Ho Lee BRD	Director/Board Member	51	-
Jeong-Hoon Kim BRD	Director/Board Member	39	-
Hyun-Mok Park PSD	President	57	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	24,181,020	12,515,048 ( 51.76 %)	272,245 ( 1.126 %)	51.76 %

Name	Equities	%	Valuation
PHARMARESEARCH BIO CO., LTD. 17.27 %	4,177,015	17.27 %	27 M ₩
Min-Ku Lee 15.33 %	3,706,930	15.33 %	24 M ₩
Young-Sik Cho 8.700 %	2,103,798	8.700 %	14 M ₩
Taek-won Lee 4.129 %	998,341	4.129 %	6 M ₩
Ho-Yeon Cho 4.095 %	990,240	4.095 %	6 M ₩
Yong-Joon Cho 3.318 %	802,362	3.318 %	5 M ₩
Gi-Hong Sung 2.654 %	641,857	2.654 %	4 M ₩
Sung-Sub Woo 1.966 %	475,434	1.966 %	3 M ₩
InterVest Co., Ltd. 1.350 %	326,552	1.350 %	2 M ₩
Young-in Kim 1.158 %	280,027	1.158 %	2 M ₩

Name	Equities	%	Valuation
CTCBIO INC. 1.13%	272,245	1.13%	1,755,311 $

CTC Bio, Inc.

#901, Geumgang Penterium IX Tower 27 Dongtancheomdansaneop 1-ro

18469, Hwaseong-si

http://www.ctcbio.com

	1st Jan change	Capi.
CTCBIO INC.	-25.14%	141M
ZOETIS INC.	-15.35%	76.23B
ELANCO ANIMAL HEALTH INCORPORATED	-9.19%	6.67B
VIRBAC	-1.11%	3.21B
VIMIAN GROUP AB	+6.08%	1.52B
JINYU BIO-TECHNOLOGY CO., LTD.	-15.13%	1.37B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-25.63%	1.24B
VETOQUINOL SA	-7.62%	1.21B
WUHAN KEQIAN BIOLOGY CO.,LTD	-10.84%	1.17B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	-.--%	1.05B

Veterinary Drugs

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Veterinary Drugs